The original trial was supported by an investigator-initiated grant from Bristol-Myers Squibb, USA. Ms. Rostamian had no conflicts.
Conference Coverage
Cognitive impairment signals subclinical vascular disease
Publish date: June 12, 2015
AT THE EUROPEAN STROKE CONFERENCE